Browse studies

Find your next paid study

1,264 recruiting studies matching your filters

Cancer CARE Beyond Walls - A Pilot of a Randomized, Pragmatic Trial of Cancer Directed Therapy Administration in the Patients' Homes Versus in Clinic

This clinical trial studies the effect of cancer directed therapy given at-home versus in the clinic for patients with cancer that may have spread from where i…

Advanced Anal CarcinomaAdvanced Biliary Tract CarcinomaAdvanced Bladder Carcinoma+41 more

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Mayo ClinicNCT05969860

Observational

Radiofrequency Ablation (RhinAer, Neuromark) vs. Cryoablation (ClariFix) of the Posterior Nasal Nerve for Chronic Rhinitis: A Randomized Controlled Trial

The goal of this clinical trial is to learn which procedural intervention most effectively reduces symptoms of chronic rhinitis (non-allergic rhinitis) in adul…

Chronic RhinitisNon-allergic Rhinitis

Estimated

~$10 – $750

Actual pay is set by the research site.

University of California, San DiegoNCT07706595

Phase 2

Prospective Study to Identify Food-Specific and Component IgE Threshold Levels That Predict Food Allergy in Patients With Elevated Total Serum IgE Levels and Atopic Dermatitis

Background: Atopic dermatitis (AD), also called eczema, makes skin dry, red, and itchy. People with AD are more likely to get a food allergy than people witho…

Milk and/or Peanut Allergy

Estimated

~$75 – $1,800

Actual pay is set by the research site.

National Institute of Allergy and Infectious Diseases (NIAID)NCT03835767

Phase 3

A Pivotal, Parallel-Arm, Phase 3, Open-Label, Active-controlled, Global, Multicenter, Randomized Basket Trial Investigating the Efficacy and Safety of Once-weekly Lonapegsomatropin Compared to Daily Somatropin in Prepubertal Children and Adolescents With Growth Failure or Short Stature Due to Growth Hormone Sufficient Disorders - Turner Syndrome, SHOX Deficiency, Small for Gestational Age, and Idiopathic Short Stature

This basket trial will enroll prepubertal children and adolescents with clinically diagnosed and genetically confirmed (if applicable) TS, SHOX-D, SGA, or ISS …

Turner SyndromeShort Stature Homeobox Gene MutationIdiopathic Short Stature+1 more

Estimated

~$50 – $2,100

Actual pay is set by the research site.

Ascendis Pharma A/S

Phase 2

A Phase 2, Open-label, Multicohort Study of Rinatabart Sesutecan (Rina-S) in Participants With Non-Small Cell Lung Cancer

This Phase 2 study will be conducted in different countries around the world with up to about 240 participants. The purpose of this study is to evaluate how w…

Non-small Cell Lung Cancer (NSCLC)

Estimated

~$75 – $3,000

Actual pay is set by the research site.

GenmabNCT07288177

Phase 1

Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas

This research is being done to test a new drug called PEEL-224 in combination with two commercially available drugs, Vincristine and Temozolomide, and to deter…

SarcomaSarcoma, EwingDesmoplastic Small Round Cell Tumor+3 more

Estimated

~$150 – $4,500

Actual pay is set by the research site.

David S Shulman, MDNCT06709495

Phase 1

A Phase 1/2, Open-Label, Multi-Center, First-in-Human Study of the Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of TPX-0005 in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements (TRIDENT-1)

Phase 1 dose escalation will determine the first cycle dose-limiting toxicities (DLTs), the maximum tolerated dose (MTD), the biologically effective dose and r…

Locally Advanced Solid TumorsMetastatic Solid Tumors

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Turning Point Therapeutics, Inc.NCT03093116

Phase 2

Phase II Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-Small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy

This pilot study is configured as a non-inferiority comparison of Performance Status 2 patients with Performance Status 0-1 patients, with the goal of demonstr…

Nonsmall Cell Lung CancerPerformance Status

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Wake Forest University Health SciencesNCT04253964

SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation

The purpose of SIBYL is to generate clinical validity data for the ability of a future version of Guardant360 developed by Guardant Health to measure response …

Non-small Cell Lung CancerColorectal CancerBreast Cancer

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Guardant Health, Inc.NCT05935384

Observational

MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial (METEOR-CRATR)

This study is a dynamically adjustable prospective longitudinal study designed to capture biospecimen (biopsy, blood, surgical) and multimodal treatment-relate…

Locally Advanced Cervical CarcinomaLocally Advanced Cervical CancerLocally Advanced Pancreas Cancer+7 more

Estimated

~$10 – $750

Actual pay is set by the research site.

Washington University School of MedicineNCT05975593

Follow-up Visit of High Risk Infants

The NICHD Neonatal Research Network's Follow-Up study is a multi-center cohort in which surviving extremely low birth-weight infants born in participating netw…

Infant, NewbornInfant, Low Birth WeightInfant, Small for Gestational Age+1 more

Estimated

~$10 – $1,125

Actual pay is set by the research site.

NICHD Neonatal Research NetworkNCT00009633

Phase 1

A Phase I Open-label, Multi-dose, Dose Escalation and Dose Expansion Study of the Oral EGFR Inhibitor PLB1004 in Non-Small Cell Lung Cancer

This is a Phase I, multicenter, open-label, dose escalation and dose expansion study to assess the safety and pharmacokinetic profile of PLB1004, a mono-anilin…

Non-Small Cell Lung Cancer

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Avistone Biotechnology Co., Ltd.NCT06046495